Advertisement

Life Time Prevention of Chronic Airway Diseases

  • Maciej Chałubiński
  • Marek L. KowalskiEmail author
Chapter
Part of the Practical Issues in Geriatrics book series (PIG)

Abstract

Chronic airway diseases, including bronchial asthma and chronic obstructive pulmonary disease (COPD), have been considered to be major causes of morbidity from childhood to old age. Both diseases may be promoted by life span exposure to environmental risk factors, such air pollution, tobacco smoke, and may also be influenced by climate changes, social background, diet, infections, and occupation. Strategies for prevention of chronic airway diseases are based on the proper identification, modification, and/or avoidance of risk factors during the lifetime.

Keywords

Asthma Chronic obstructive pulmonary disease (COPD) Tobacco Air pollution Obesity Exposome 

References

  1. 1.
    Graham LM, Eid N (2015) The impact of asthma exacerbations and preventive strategies. Curr Med Res Opin 31:825–835CrossRefGoogle Scholar
  2. 2.
    Griswold SK, Nordstrom CR, Clark S et al (2005) Asthma exacerbations in North American adults: who are the “frequent fliers” in the emergency department? Chest 127:1579–1586CrossRefGoogle Scholar
  3. 3.
  4. 4.
    Gibson PG, McDonald VM, Marks GB (2010) Asthma in older adults. Lancet 376:803–813CrossRefGoogle Scholar
  5. 5.
    Milanese M, Di Marco F, Corsico AG et al (2014) Asthma control in elderly asthmatics. An Italian observational study. Respir Med 108:1091–1099CrossRefGoogle Scholar
  6. 6.
    Global Strategy for the Diagnosis (2017) Management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung diseaseGoogle Scholar
  7. 7.
    Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma, 2017Google Scholar
  8. 8.
    Chinnaswamy S, Wardzynska A, Pawelczyk M et al (2017) A functional IFN-lambda4-generating DNA polymorphism could protect older asthmatic women from aeroallergen sensitization and associate with clinical features of asthma. Sci Rep 7:10500CrossRefGoogle Scholar
  9. 9.
    Steelant B, Farre R, Wawrzyniak P et al (2016) Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. J Allergy Clin Immunol 137:1043–1053 e5CrossRefGoogle Scholar
  10. 10.
    Burbank AJ, Sood AK, Kesic MJ et al (2017) Environmental determinants of allergy and asthma in early life. J Allergy Clin Immunol 140:1–12CrossRefGoogle Scholar
  11. 11.
    Chalubinski M, Kowalski ML (2006) Endocrine disrupters—potential modulators of the immune system and allergic response. Allergy 61:1326–1335CrossRefGoogle Scholar
  12. 12.
    Kowalski ML, Wardzynska A, Studzinska M et al (2017) Cytomegalovirus DNA is highly prevalent in the blood of patients with asthma and is associated with age and asthma traits. Allergy 72:2035–2038CrossRefGoogle Scholar
  13. 13.
    Bunyavanich S, Rifas-Shiman SL, Platts-Mills TA et al (2014) Peanut, milk, and wheat intake during pregnancy is associated with reduced allergy and asthma in children. J Allergy Clin Immunol 133:1373–1382CrossRefGoogle Scholar
  14. 14.
    Yepes-Nunez JJ, Brozek JL, Fiocchi A et al (2018) Vitamin D supplementation in primary allergy prevention: systematic review of randomized and non-randomized studies. Allergy 73:37–49CrossRefGoogle Scholar
  15. 15.
    Takkouche B, Gonzalez-Barcala FJ, Etminan M et al (2008) Exposure to furry pets and the risk of asthma and allergic rhinitis: a meta-analysis. Allergy 63:857–864CrossRefGoogle Scholar
  16. 16.
    Burke H, Leonardi-Bee J, Hashim A et al (2012) Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 129:735–744CrossRefGoogle Scholar
  17. 17.
    Gehring U, Wijga AH, Hoek G et al (2015) Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study. Lancet Respir Med 3:933–942CrossRefGoogle Scholar
  18. 18.
    House JS, Wyss AB, Hoppin JA et al (2017) Early-life farm exposures and adult asthma and atopy in the agricultural lung health study. J Allergy Clin Immunol 140:249–256 e14CrossRefGoogle Scholar
  19. 19.
    Forsberg A, West CE, Prescott SL et al (2016) Pre- and probiotics for allergy prevention: time to revisit recommendations? Clin Exp Allergy 46:1506–1521CrossRefGoogle Scholar
  20. 20.
    Zhang GQ, Hu HJ, Liu CY et al (2016) Probiotics for prevention of atopy and food hypersensitivity in early childhood: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 95:e2562CrossRefGoogle Scholar
  21. 21.
    Mochizuki H, Kusuda S, Okada K et al (2017) Palivizumab prophylaxis in preterm infants and subsequent recurrent wheezing. Six-year follow-up study. Am J Respir Crit Care Med 196:29–38CrossRefGoogle Scholar
  22. 22.
    Jartti T, Gern JE (2017) Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol 140:895–906CrossRefGoogle Scholar
  23. 23.
    Wahn U (2017) Preventing new sensitization and asthma onset by allergen immunotherapy: the current evidence. Curr Opin Allergy Clin Immunol 17:443–446CrossRefGoogle Scholar
  24. 24.
    Agusti A, Celli B (2017) Natural history of COPD: gaps and opportunities. ERJ Open Res 3:00117CrossRefGoogle Scholar
  25. 25.
    Kohansal R, Martinez-Camblor P, Agusti A et al (2009) The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 180:3–10CrossRefGoogle Scholar
  26. 26.
    Calverley PM, Anderson JA, Celli B et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775–789CrossRefGoogle Scholar
  27. 27.
    Vestbo J, Anderson JA, Brook RD et al (2017) Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet 387:1817–1826CrossRefGoogle Scholar
  28. 28.
    McGeachie MJ (2017) Childhood asthma is a risk factor for the development of chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol 17:104–109CrossRefGoogle Scholar
  29. 29.
    Bui DS, Burgess JA, Lowe AJ et al (2017) Childhood lung function predicts adult chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap syndrome. Am J Respir Crit Care Med 196:39–46CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Immunology and Allergy, Healthy Ageing Research Center (HARC)Medical University of LodzŁódźPoland

Personalised recommendations